pH News and Research

RSS

pH comes from the term “power of Hydrogen”, or the hydrogen ion concentration present in a given solution. It helps to measure the acidity or alkalinity of a substance.

Simple eye test spots patients at risk for postoperative cognitive dysfunction

Identifying an older patient who is at risk for post-operative cognitive dysfunction might be done in the blink of an eye – literally.

12 Dec 2023

Stem cell therapy trial shows promise for regenerative treatment of heart failure

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

12 Dec 2023

Liquid biopsy may offer new tools for personalized immunotherapy in lung cancer

Using a "liquid biopsy" to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with advanced lung cancers are responding to immunotherapies and which patients may develop immune-related side effects several months later, according to research directed by investigators at the Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy and Allegheny Health Network Cancer Institute in Pittsburgh.

12 Dec 2023

Evaluating the health risks associated with dietary exposure to metals

The problem of foodborne metal contamination has taken on new urgency, thanks in part to a 2021 US Congressional Report detailing high levels of metals found in infant food pulled off grocery shelves.

12 Dec 2023

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.

From Himedia Laboratories Private Limited 12 Dec 2023

Lymphatic fluid from surgical drains could inform more precise treatments for head and neck cancer

Lymphatic fluid from surgical drains, which is usually tossed in the trash, is a treasure in the hands of University of Pittsburgh and Washington University School of Medicine in St. Louis researchers who found that this liquid could inform more precise treatments for patients with head and neck cancer caused by human papillomavirus (HPV).

11 Dec 2023

Quizartinib extends life and enhances wellbeing for AML patients with key mutation

In a study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.

11 Dec 2023

Pandemic stressors overwhelm genetic resilience to depression in college students

Living through a historic pandemic while handling the stress of the first year of college sent one-third of students in a new study into clinical depression. That's double the percentage seen in previous years of the same study.

11 Dec 2023

Novel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytes

For decades, scientists have noted an intriguing similarity between a deficiency in vitamin B12 – an essential nutrient that supports healthy development and functioning of the central nervous system (CNS) – and multiple sclerosis (MS), a chronic disease in which the body's immune system attacks the CNS and which can produce neurodegeneration.

11 Dec 2023

Non-invasive cancer monitoring takes a leap forward with new microfluidic technology

Monitoring cancer cells effectively can help physicians with treatment and management, thus reducing cancer-related mortality.

11 Dec 2023

CAR-T cell therapy remains viable for patients in lymphoma remission, study finds

A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins.

11 Dec 2023

Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients

Older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who were not good candidates for the standard treatment of intensive chemotherapy had a median overall survival (OS) of 6.5 years on an alternate regimen of dasatinib and blinatumomab.

11 Dec 2023

Study explores the intricate gut-brain-liver connection and its impact on health

Study reviews the gut-brain-liver axis, revealing the complex interplay between these organs in health and disease and the implications for therapeutic interventions, focusing on how gut microbiota affects liver and brain health.

10 Dec 2023

Expanding the toolbox for drug design: New enzymes for tailoring molecules

Simon Schröder has worked out how enzymes can be used to more easily form the desired bond between two nitrogen atoms.

8 Dec 2023

Study unlock secrets of Zika virus's multipurpose enzyme and reveals therapeutic vulnerability

Viruses have limited genetic material - and few proteins - so all the pieces must work extra hard. Zika is a great example; the virus only produces 10 proteins.

8 Dec 2023

T cells can recognize and fight the "Pirola" variant, new study suggests

In August, researchers detected a new SARS-CoV-2 "variant of concern" in patients in Israel and Denmark.

8 Dec 2023

Study shows decline in post-surgery opioid prescriptions, but urges continued efforts

Post-surgery pain relief has shifted away from opioid-containing medications over the past seven years, but the downward trend has slowed since 2020, a new study shows.

7 Dec 2023

Flaxseed lignans found to influence gut microbiome and breast cancer risk

A new study demonstrates that the human gut microbiome may be a factor in breast health. Lifestyle and diet have long been known to affect human health.

7 Dec 2023

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

7 Dec 2023

Vanderbilt's potential schizophrenia treatment enters phase 1 clinical trials

A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials - the third WCNDD therapeutic to reach that benchmark.

7 Dec 2023

pH News and Research

Further Reading

Simple eye test spots patients at risk for postoperative cognitive dysfunction

Stem cell therapy trial shows promise for regenerative treatment of heart failure

Liquid biopsy may offer new tools for personalized immunotherapy in lung cancer

Evaluating the health risks associated with dietary exposure to metals

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

Lymphatic fluid from surgical drains could inform more precise treatments for head and neck cancer

Quizartinib extends life and enhances wellbeing for AML patients with key mutation

Pandemic stressors overwhelm genetic resilience to depression in college students

Novel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytes

Non-invasive cancer monitoring takes a leap forward with new microfluidic technology

CAR-T cell therapy remains viable for patients in lymphoma remission, study finds

Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients

Study explores the intricate gut-brain-liver connection and its impact on health

Expanding the toolbox for drug design: New enzymes for tailoring molecules

Study unlock secrets of Zika virus's multipurpose enzyme and reveals therapeutic vulnerability

T cells can recognize and fight the "Pirola" variant, new study suggests

Study shows decline in post-surgery opioid prescriptions, but urges continued efforts

Flaxseed lignans found to influence gut microbiome and breast cancer risk

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Vanderbilt's potential schizophrenia treatment enters phase 1 clinical trials

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo